We recommend its use in cases with prolonged ischemia (over six to eight hours) and vein bleeding from five to 10 minutes with hemodynamic support to eliminate free radicals (including myoglobin, CPK, and potassium) and reduce the risk of acute renal failure or lethal consequences, as per the literature. This evidence concerns the gene PIK3C2A and acute kidney injury.